Prestige Consumer Healthcare Inc. (PBH) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Prestige Consumer Healthcare Inc. (PBH:NYSE), powered by AI.

Current Price
$47.82
P/E Ratio
11.1
Market Cap
2.4B
Sector
Healthcare
What is the Prestige Consumer Healthcare Inc. stock price forecast?

Prestige Consumer Healthcare Inc. is currently trading at $47.82. View real-time AI analysis on Alpha Lenz.

What is Prestige Consumer Healthcare Inc. insider trading activity?

View the latest insider trading data for Prestige Consumer Healthcare Inc. on Alpha Lenz.

What is Prestige Consumer Healthcare Inc.'s P/E ratio?

Prestige Consumer Healthcare Inc.'s P/E ratio is 11.1.

Prestige Consumer Healthcare Inc.

NYSE · PBH
$47.82+0.25(+0.53%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Prestige Consumer Healthcare Inc.'s future dividend policy...
Alpha Chat Insight

Prestige Consumer Healthcare Inc. trades at a P/E of 11.1 (undervalued) with solid ROE of 12.3%. Operating margin of 30.7% indicates strong profitability.

Ask for details

Company Overview

Prestige Consumer Healthcare Inc. is a corporation involved in the production and distribution of over-the-counter healthcare and household cleaning products. This company primarily focuses on providing solutions for everyday health and wellness needs. It operates within the consumer staples sector, influencing industries such as healthcare, wellness, and personal care goods. Prestige Consumer Healthcare Inc. offers a range of well-known products that cater to personal health care, featuring brands that span various categories, including analgesics, cough and cold remedies, gastrointestinal aids, and oral care products. The company sells its products through multiple channels including drug stores, groceries, and e-commerce platforms, reaching a broad consumer base. Prestige Consumer Healthcare Inc.'s role in the market centers on addressing consumer demands for accessible and reliable healthcare products, reinforcing its significance as a key player in enhancing and maintaining health across diverse demographics.

CEOMr. Ronald M. Lombardi CPA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees600

Company Statistics

FY 2025

Profile

$2.38BMarket Cap
$1.14BRevenue
0.00Shares Out
600Employees

Margins

55.76%Gross
32.91%EBITDA
30.70%Operating
24.98%Pre-Tax
18.86%Net

Valuation

11.07P/E
1.30P/B
2.09EV/Sales
8.87EV/EBITDA
9.77P/FCF

Growth (CAGR)

1.54%Rev 3Yr
3.39%Rev 5Yr
1.81%Op Inc 3Yr
3.71%Op Inc 5Yr
1.48%Net Inc 3Yr
8.57%Net Inc 5Yr

Returns

6.39%ROA
12.30%ROE
9.87%ROIC

Financial Health

$97.88MCash & Cash Equivalents
$1.47BNet Debt
85.42%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Prestige Consumer Healthcare Inc. (ticker: PBH) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 600 employees. Market cap is $2.4B.

The current price is $47.82 with a P/E ratio of 11.07x and P/B of 1.3x.

ROE is 12.30% and operating margin is 30.70%. Annual revenue is $1.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Prestige Consumer Healthcare Inc. (PBH) Stock Forecast 2026 $47.82 — Price, Financials & Analyst Targets | Alpha Lenz